| Filed On | Filing |
|---|---|
| 06 Nov 2018 |
Form 4/A: Maraganore John, Director
Sold 0 shares |
| 10 Aug 2018 |
Form 4/A: Biller Scott, Chief Scientific Officer
Exercised 3,000 Stock option (right to buy) |
| 10 Aug 2018 |
Form 4/A: Biller Scott, Chief Scientific Officer
Exercised 3,000 Stock option (right to buy) |
| 10 Aug 2018 |
Form 4/A: Biller Scott, Chief Scientific Officer
Exercised 15,177 Stock option (right to buy) |
| 10 Aug 2018 |
Form 4/A: Biller Scott, Chief Scientific Officer
Exercised 3,000 Stock option (right to buy) |
| 10 Aug 2018 |
Form 4/A: Biller Scott, Chief Scientific Officer
Exercised 3,000 Stock option (right to buy) |
| 10 Aug 2018 |
Form 4/A: Biller Scott, Chief Scientific Officer
Exercised 4,137 Stock option (right to buy) |
| 31 Jan 2018 |
Form 4/A: Celgene Corp /DE/, 10% owner and 3 others
Bought 851,154 shares ($57M) |
| 25 Jan 2018 |
Form 4/A: Hoerter Steven L., Chief Commercial Officer
Exercised 25,000 Stock option (right to buy) |
| 25 Jan 2018 |
Form 4/A: Schenkein David P, Director
Exercised 6,000 Stock option (right to buy) |
| 23 Mar 2016 |
Form 4/A: Cantley Lewis Clayton Jr., Director
Sold 2,722 shares ($162K) · Sold 6,982 shares ($419K) |
Loading...